Tetramerization-defects of p53 result in aberrant ubiquitylation and transcriptional activity

Area of Science:

• Molecular Biology
• Cancer Biology
• Protein Biochemistry

Background:

• The tumor suppressor p53 is crucial for regulating cell cycle, senescence, and apoptosis.
• p53 functions as a tetramer, and its stability and activity are tightly regulated.
• Mutations in p53 are common in cancer, often affecting its DNA-binding and oligomerization domains.

Purpose of the Study:

• To investigate the impact of single point mutations in the p53 oligomerization domain (OD) on p53 tetramerization, transcription, ubiquitylation, and stability.
• To determine how p53 OD mutants interact with wild-type p53 and affect its function.
• To assess the functional consequences of p53 OD mutations on p53-dependent gene expression.

Main Methods:

• Docking and molecular dynamics simulations to predict mutant behavior.
• Transient and stable expression of p53 mutants in wild-type and p53-null cells.
• Analysis of p53 tetramerization, Mdm2-dependent ubiquitylation, proteasomal degradation, and p53-dependent gene expression (e.g., Bax, PUMA).

Main Results:

• p53 OD mutants exhibited functional defects in transcription and Mdm2-dependent ubiquitylation.
• Mutants unable to form tetramers were degraded by the 20S proteasome.
• Despite lower stability, p53 OD mutants formed heterotetramers with wild-type p53, interfering with ubiquitylation and altering p53-dependent gene expression.
• A patient-derived mutant (L330R) showed significant disruption of p53-dependent gene expression.

Conclusions:

• p53 OD mutations impair p53's transcriptional activity and stability.
• p53 OD mutants can dominantly interfere with wild-type p53 function through heterotetramer formation.
• Ubiquitylation defects in p53 OD mutants contribute to altered p53-dependent gene expression, impacting its tumor suppressor functions.